Reversible Myc hypomorphism identifies a key Myc-dependency in early cancer evolution

por Sodir, Nicole M., Pellegrinet, Luca, Kortlever, Roderik M., Campos, Tania, Kwon, Yong-Won, Kim, Shinseog, Garcia, Daniel, Perfetto, Alessandra, Anastasiou, Panayiotis, Swigart, Lamorna Brown, Arends, Mark J., Littlewood, Trevor D., Evan, Gerard I.
Publicado 2022

Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk

por Magbanua, Mark Jesus M., Li, Wen, Wolf, Denise M., Yau, Christina, Hirst, Gillian L., Swigart, Lamorna Brown, Newitt, David C., Gibbs, Jessica, Delson, Amy L., Kalashnikova, Ekaterina, Aleshin, Alexey, Zimmermann, Bernhard, Chien, A. Jo, Tripathy, Debu, Esserman, Laura, Hylton, Nola, van ‘t Veer, Laura
Publicado 2021

Development and testing of a polygenic risk score for breast cancer aggressiveness

por Shieh, Yiwey, Roger, Jacquelyn, Yau, Christina, Wolf, Denise M., Hirst, Gillian L., Swigart, Lamorna Brown, Huntsman, Scott, Hu, Donglei, Nierenberg, Jovia L., Middha, Pooja, Heise, Rachel S., Shi, Yushu, Kachuri, Linda, Zhu, Qianqian, Yao, Song, Ambrosone, Christine B., Kwan, Marilyn L., Caan, Bette J., Witte, John S., Kushi, Lawrence H., ‘T Veer, Laura van, Esserman, Laura J., Ziv, Elad
Publicado 2023